Form 10-K Nurix Therapeutics, Inc. For: Nov 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- ICC sets July 24 vote on whether to remove chief prosecutor Karim Khan, WSJ reports
Nurix (NRIX) PT Lowered to $28 at Needham
January 29, 2025 7:59 AM ESTNeedham analyst Gil Blum lowered the price target on Nurix (NASDAQ: NRIX) to $28.00 (from $29.00) while maintaining a Buy rating.
The analyst comments "Financials and Model Updates. In 2024, Nurix received ~$13M in collaboration revenue from its partners including a $5M milestone... More
